#United States #GT Medical #Tempe, Arizona #Allegheny Health #GammaTile Center

GT Medical Technologies Celebrates New Center of Excellence Designation

GT Medical Technologies, a company dedicated to enhancing the lives of patients battling brain tumors, has proudly announced that the Allegheny Health Network's Neuroscience Institute has received the prestigious GammaTile® Center of Excellence designation. This recognition acknowledges the exceptional leadership demonstrated in patient education, clinical skills, and commitment to advancing treatment for brain tumors.

The GammaTile program aims to highlight those healthcare institutions and professionals who excel in the application of cutting-edge technologies for treating brain tumors. Institutions that achieve this designation must show a significant depth of expertise and adhere to stringent clinical criteria, which include a minimum number of annual cases and a commitment to continual educational advancement.

Leadership and Recognition

Among the notable professionals recognized under this program are:

• - Dr. Matthew J. Shepard, Neurosurgeon
• - Dr. Rodney Wegner, Radiation Oncologist
• - Dr. Stephen Karlovits, Radiation Oncologist
• - Dan Pavord, Physicist
• - Dr. Alex Yu, Neurosurgeon
• - Dr. Rocco Dabecco, Neurosurgeon
• - Dr. Elena Fomchenko, Neurosurgeon

Dr. Matthew Shepard, a key contributor at Allegheny General Hospital, expressed pride in receiving such an accolade: "Being recognized as a GammaTile Center of Excellence is a testament to our dedication to brain tumor treatment advancements. GammaTile technology marks a major leap forward, enabling effective interventions when patient lives hang in the balance. We are keen to remain at the forefront of innovative solutions for brain tumor management."

What is GammaTile?

GammaTile is revolutionizing how operable brain tumors are treated. Unlike traditional methods which often experience a disconnect between tumor removal and the initiation of radiation therapy, GammaTile introduces a novel solution. The device is a bioabsorbable collagen implant that houses radioactive seeds, strategically placed directly into the surgical cavity during tumor resection.

This innovative delivery mechanism allows for immediate, focused radiation targeting residual cancer cells right at the tumor site, eliminating the usual gap seen in conventional treatments. By acting fast and directly, GammaTile not only simplifies the treatment protocol but is designed to maximize the chances of eliminating any remaining cancerous cells, thus significantly lowering the risk of tumor regrowth.

Since its introduction to the U.S. market in March 2020, GammaTile has been adopted by over 100 distinguished medical centers, further showcasing its acceptance and effectiveness in both academic and community-based healthcare settings. This growing popularity underlines the potential GammaTile has to change the landscape of brain tumor treatments significantly!

About GT Medical Technologies

GT Medical Technologies was founded by a passionate group of specialists in brain tumor treatment, unified by the goal of addressing the unmet needs within this medical field. The company showcases a long-term commitment towards continuous innovation that elevates patient care standards. Its flagship offering, GammaTile, not only underscores this commitment but has also positioned the company as a leader in advancing brain tumor treatments.

For additional information, visit gammatile.com and follow @GammaTile on social media platforms including Facebook, Instagram, LinkedIn, and X.

In conclusion, the designation of Allegheny Health Network as a GammaTile Center of Excellence is a significant stride forward for brain tumor treatment and reflects the tremendous dedication of healthcare professionals to improve patient outcomes through innovative therapy methods.